Proteomic Profiling of Tears in Blau Syndrome Patients in Identification of Potential Disease Biomarkers

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Aug 10

PMID 39125957

Authors

Paola Galozzi

Sara Bindoli

Chiara Baggio

Ilaria Battisti

Andrea Leonardi

Daniela Basso

Giorgio Arrigoni

Paolo Sfriso

Affiliations

Soon will be listed here.

Abstract

Blau syndrome (BS) is a rare autoinflammatory granulomatosis characterized by granulomatous arthritis, uveitis, and dermatitis. Ocular complications are particularly severe in BS, significantly contributing to morbidity. This study aims to identify potential biomarkers for BS ocular degeneration through proteomic profiling of tear samples from affected patients. Seven subjects from the same family, including four carriers of the BS-associated mutation (p.E383K), were recruited alongside healthy controls. Tear samples were collected using Schirmer strips and analyzed via mass spectrometry. A total of 387 proteins were identified, with significant differences in protein expression between BS patients, healthy familial subjects, and healthy controls. Key findings include the overexpression of alpha-2-macroglobulin (A2M) and immunoglobulin heavy constant gamma 4 (IGHG4) in BS patients. Bioinformatic analysis revealed that differentially expressed proteins are involved in acute-phase response, extracellular exosome formation, and protein binding. Notably, neutrophils' azurophilic granule components, as azurocidin (AZU1), myeloperoxidases (MPO), and defensins (DEFA3), were highly expressed in the most severely affected subject, suggesting a potential role of neutrophils in BS ocular severity. These proteins might be promising biomarkers for ocular involvement in BS, facilitating early detection and tailored treatment strategies.

References

Mun Y, Hwang J, Shin Y . Role of Neutrophils on the Ocular Surface. Int J Mol Sci. 2021; 22(19). PMC: 8508808. DOI: 10.3390/ijms221910386. View

Wouters C, Maes A, Foley K, Bertin J, Rose C . Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014; 12:33. PMC: 4136643. DOI: 10.1186/1546-0096-12-33. View

Harada J, Nakajima T, Kanazawa N . A Case of Blau Syndrome with NOD2 E383K Mutation. Pediatr Dermatol. 2016; 33(6):e385-e387. DOI: 10.1111/pde.12908. View

Sun C, Cao C, Zhao T, Guo H, Fleming B, Owens B . A2M inhibits inflammatory mediators of chondrocytes by blocking IL-1β/NF-κB pathway. J Orthop Res. 2022; 41(1):241-248. DOI: 10.1002/jor.25348. View

Siraki A . The many roles of myeloperoxidase: From inflammation and immunity to biomarkers, drug metabolism and drug discovery. Redox Biol. 2021; 46:102109. PMC: 8403760. DOI: 10.1016/j.redox.2021.102109. View

Angeles-Han S, Yeh S, Patel P, Duong D, Jenkins K, Rouster-Stevens K . Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study. J Ophthalmic Inflamm Infect. 2018; 8(1):17. PMC: 6191408. DOI: 10.1186/s12348-018-0156-5. View

Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N . Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003; 110(10):2040-4. DOI: 10.1016/S0161-6420(03)00717-6. View

Saulsbury F, Wouters C, Martin T, Austin C, Doyle T, Goodwin K . Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009; 60(6):1804-6. DOI: 10.1002/art.24532. View

Punzi L, Furlan A, Podswiadek M, Gava A, Valente M, Marchi M . Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev. 2008; 8(3):228-32. DOI: 10.1016/j.autrev.2008.07.034. View

10.

Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L . Blau syndrome, clinical and genetic aspects. Autoimmun Rev. 2012; 12(1):44-51. DOI: 10.1016/j.autrev.2012.07.028. View

11.

van Duist M, Albrecht M, Podswiadek M, Giachino D, Lengauer T, Punzi L . A new CARD15 mutation in Blau syndrome. Eur J Hum Genet. 2005; 13(6):742-7. DOI: 10.1038/sj.ejhg.5201404. View

12.

Jang J, Bruse S, Liu Y, Duffy V, Zhang C, Oyamada N . Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity. Free Radic Biol Med. 2013; 68:80-6. PMC: 3941192. DOI: 10.1016/j.freeradbiomed.2013.11.028. View

13.

Cater J, Kumita J, Zeineddine Abdallah R, Zhao G, Bernardo-Gancedo A, Henry A . Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer's-associated amyloid beta peptide. Proc Natl Acad Sci U S A. 2019; 116(13):6101-6110. PMC: 6442606. DOI: 10.1073/pnas.1817298116. View

14.

Galozzi P, Negm O, Greco E, Alkhattabi N, Gava A, Sfriso P . Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome. Reumatismo. 2015; 66(4):277-84. DOI: 10.4081/reumatismo.2014.772. View

15.

Villanueva-Mendoza C, Arellanes-Garcia L, Cubas-Lorenzo V, Jimenez-Martinez M, Flores-Suarez L, Zenteno J . Familial case of Blau syndrome associated with a CARD15/NOD2 mutation. Ophthalmic Genet. 2010; 31(3):155-8. DOI: 10.3109/13816810.2010.492818. View

16.

Eidet J, Jorstad O, Fostad I, Olstad O, Sorland R, Moe M . Unilateral acute anterior uveitis is associated with ipsilateral changes in the tear fluid proteome that involves the LXR/RXR pathway. J Ophthalmic Inflamm Infect. 2020; 10(1):13. PMC: 7250997. DOI: 10.1186/s12348-020-00204-4. View

17.

Hagan S, Martin E, Enriquez-de-Salamanca A . Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J. 2016; 7:15. PMC: 4942926. DOI: 10.1186/s13167-016-0065-3. View

18.

Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y . Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the mutation. Ann Rheum Dis. 2020; 79(11):1492-1499. DOI: 10.1136/annrheumdis-2020-217320. View

19.

Lai K, Liao X, Aljufairi F, Man Wong Y, Chiu J, Mak H . Ocular Surface Evaluation in Immunoglobulin G4-Related Ophthalmic Disease. Am J Ophthalmol. 2023; 256:90-96. DOI: 10.1016/j.ajo.2023.07.031. View

20.

Papadea C, Check I . Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Crit Rev Clin Lab Sci. 1989; 27(1):27-58. DOI: 10.3109/10408368909106589. View